Company Presentation • 27 May 2024 14:00
Company Presentation • 19 May 2022 23:00
Company Presentation • 22 Jun 2023 23:00
Company Presentation • 13 Nov 2023 20:00
No more presentations
Search or
𝛼SK
𝛼SKENTITY
Cellectis SA (CLLS US)
Cellectis SA (CLLS US)
3
Analysis
Health Care • France
Cellectis SA is a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR-T cells (UCART). The company's mission is to develop a new generation of cancer therapies based on engineered T-cells.
morex